BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34097299)

  • 1. Identification of circulating regulatory T lymphocytes with membrane markers - a new multiparameter flow cytometry protocol.
    Piekarska A; Pérès M; Toton M; Kulczycka M; Lewandowski K; Vergez F
    Folia Histochem Cytobiol; 2021; 59(2):75-85. PubMed ID: 34097299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Regulatory T Cells in Preterm and Term Infants.
    Zahran AM; Saad K; Abdel-Raheem YF; Elsayh KI; El-Houfey AA; Aboul-Khair MD; Alblihed MA
    Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):49-54. PubMed ID: 30374518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human treg cells are characterized by low/negative CD6 expression.
    Garcia Santana CA; Tung JW; Gulnik S
    Cytometry A; 2014 Oct; 85(10):901-8. PubMed ID: 25088497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subpopulations of T Regulatory Cells in Blood Stem Cell Harvests Influence Development of Acute Graft Versus Host Disease in Allogeneic Transplant Recipients.
    Roschupkina T; Juliusson G
    Cytometry B Clin Cytom; 2018 Mar; 94(2):264-269. PubMed ID: 27479496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subpopulations of equine blood lymphocytes expressing regulatory T cell markers.
    Robbin MG; Wagner B; Noronha LE; Antczak DF; de Mestre AM
    Vet Immunol Immunopathol; 2011 Mar; 140(1-2):90-101. PubMed ID: 21208665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
    Åkesson K; Tompa A; Rydén A; Faresjö M
    Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of absolute counts of circulating regulatory T cells in cynomolgus macaques using an optimized flow cytometric method.
    Clark SM; Narayanan PK; Fort MM
    Toxicol Pathol; 2012; 40(1):107-12. PubMed ID: 22033502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn's disease.
    Khalili A; Ebrahimpour S; Maleki I; Abediankenari S; Afrouzi MM
    Rom J Intern Med; 2018 Sep; 56(3):158-166. PubMed ID: 29453928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of FOXP3
    Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
    Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.
    Santegoets SJ; Dijkgraaf EM; Battaglia A; Beckhove P; Britten CM; Gallimore A; Godkin A; Gouttefangeas C; de Gruijl TD; Koenen HJ; Scheffold A; Shevach EM; Staats J; Taskén K; Whiteside TL; Kroep JR; Welters MJ; van der Burg SH
    Cancer Immunol Immunother; 2015 Oct; 64(10):1271-86. PubMed ID: 26122357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified flow cytometry method for objective estimation of human CD4
    Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
    Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4dimCD25bright Treg cell frequencies above a standardized gating threshold are similar in asthmatics and controls.
    Hoffmann HJ; Malling TM; Topcu A; Ryder LP; Nielsen KR; Varming K; Dahl R; Omland O; Sigsgaard T
    Cytometry A; 2007 Jun; 71(6):371-8. PubMed ID: 17458883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal cells recruit and regulate T regulatory cells.
    Di Ianni M; Del Papa B; De Ioanni M; Moretti L; Bonifacio E; Cecchini D; Sportoletti P; Falzetti F; Tabilio A
    Exp Hematol; 2008 Mar; 36(3):309-18. PubMed ID: 18279718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.
    Klein S; Kretz CC; Krammer PH; Kuhn A
    J Invest Dermatol; 2010 Feb; 130(2):492-9. PubMed ID: 19940860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects.
    Saison J; Demaret J; Venet F; Chidiac C; Malcus C; Poitevin-Later F; Tardy JC; Ferry T; Monneret G
    Cytometry B Clin Cytom; 2013; 84(1):50-4. PubMed ID: 23019018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
    Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
    Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
    Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
    J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.